Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk

• Published in: Frontiers in cellular neuroscience Vol. 15; p. 759571
• Main Authors: Booms, Alix, Coetzee, Gerhard A.
• Format: Journal Article
• Language: English
• Published: Lausanne Frontiers Research Foundation 04-10-2021; Frontiers Media S.A
• Subjects: alpha-synuclein; Autophagy; Cellular Neuroscience; Central nervous system; Cytokines; differentiation; Dopamine receptors; Health risk assessment; hematopoietic progenitors; Immune response; Macrophages; Microglia; Movement disorders; Mutation; Neurodegenerative diseases; Parkinson's disease; Phagocytosis; Proteins; Regulation; Risk factors; SNAP receptors; SNCA; Synuclein
• ISSN: 1662-5102; 1662-5102
• DOI: 10.3389/fncel.2021.759571

Alpha-synuclein accumulation in dopaminergic neurons is one of the primary features of Parkinson’s disease (PD). Despite its toxic properties during PD, alpha-synuclein has some important physiological functions. Although the activity of the protein has been extensively studied in neurons, the protein is also expressed in other cell types including immune cells and glia. Genetic studies show that mutations in synuclein alpha (
SNCA
), the gene that encodes alpha-synuclein, and alterations in its expression levels are a significant risk factor for PD, which likely impact the functions of a broad range of cell types. The consequences of altered
SNCA
expression in other cell types is beginning to be explored. Microglia, the primary macrophage population in the Central Nervous System (CNS), for example, are affected by variations in alpha-synuclein levels and functions. Studies suggest that deviations of alpha-synuclein’s normal activity influence hematopoiesis, the process that gives rise to microglia, and microglia’s immune functions. Alpha-synuclein levels also dictate the efficiency of SNARE-mediated vesicle formation, which could influence autophagy and cytokine release in microglia. Starting from the time of conception, these effects could impact one’s risk for developing PD. Further studies are needed to determine the physiological role of alpha-synuclein and how the protein is affected during PD in non-neuronal cells such as microglia. In this review we will discuss the known roles of alpha-synuclein in differentiation, immune responses, and vesicle formation, with insights into how abnormal alpha-synuclein expression and activity are linked to altered functions of microglia during PD.